Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8803380rdf:typepubmed:Citationlld:pubmed
pubmed-article:8803380lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C0242402lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C1457887lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C0030193lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C1707251lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C0220908lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C1707391lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C0237519lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C0205265lld:lifeskim
pubmed-article:8803380lifeskim:mentionsumls-concept:C1555582lld:lifeskim
pubmed-article:8803380pubmed:issue3lld:pubmed
pubmed-article:8803380pubmed:dateCreated1996-11-12lld:pubmed
pubmed-article:8803380pubmed:abstractTextCancer patients suffer multiple symptoms and require numerous drug therapies. Parenteral administration of multiple medications from a single container can simplify drug regimens for patient self-administration. This simplification reduces drug preparation costs and risk of infection. Therapeutic options are limited by the lack of published information on the compatibility of opioids and adjuvant drugs. We report the results of a study evaluating the physical compatibility of injectable opioids with selected drugs for pain and symptom management. Fentanyl citrate, hydromorphone hydrochloride, methadone hydrochloride, and morphine sulfate solutions were physically compatible with 14 of 15 supportive care drugs tested through visual examination using a high intensity light beam and through measured examination using a turbidimeter over a range of times up to 48 hr. Phenytoin sodium was the only drug found to be incompatible with all opioid solutions tested. This compatibility information will assist clinicians in selecting the most efficient, safe, and cost-effective supportive care drug regimen.lld:pubmed
pubmed-article:8803380pubmed:languageenglld:pubmed
pubmed-article:8803380pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8803380pubmed:citationSubsetIMlld:pubmed
pubmed-article:8803380pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8803380pubmed:statusMEDLINElld:pubmed
pubmed-article:8803380pubmed:monthSeplld:pubmed
pubmed-article:8803380pubmed:issn0885-3924lld:pubmed
pubmed-article:8803380pubmed:authorpubmed-author:TrisselL ALAlld:pubmed
pubmed-article:8803380pubmed:authorpubmed-author:WeinsteinS...lld:pubmed
pubmed-article:8803380pubmed:authorpubmed-author:ChandlerS WSWlld:pubmed
pubmed-article:8803380pubmed:issnTypePrintlld:pubmed
pubmed-article:8803380pubmed:volume12lld:pubmed
pubmed-article:8803380pubmed:ownerNLMlld:pubmed
pubmed-article:8803380pubmed:authorsCompleteYlld:pubmed
pubmed-article:8803380pubmed:pagination168-71lld:pubmed
pubmed-article:8803380pubmed:dateRevised2006-8-15lld:pubmed
pubmed-article:8803380pubmed:meshHeadingpubmed-meshheading:8803380-...lld:pubmed
pubmed-article:8803380pubmed:meshHeadingpubmed-meshheading:8803380-...lld:pubmed
pubmed-article:8803380pubmed:meshHeadingpubmed-meshheading:8803380-...lld:pubmed
pubmed-article:8803380pubmed:meshHeadingpubmed-meshheading:8803380-...lld:pubmed
pubmed-article:8803380pubmed:meshHeadingpubmed-meshheading:8803380-...lld:pubmed
pubmed-article:8803380pubmed:year1996lld:pubmed
pubmed-article:8803380pubmed:articleTitleCombined administration of opioids with selected drugs to manage pain and other cancer symptoms: initial safety screening for compatibility.lld:pubmed
pubmed-article:8803380pubmed:affiliationDivision of Pharmacy, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.lld:pubmed
pubmed-article:8803380pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8803380pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8803380pubmed:publicationTypeControlled Clinical Triallld:pubmed